References
- Akhade VS, Pal D, Kanduri C. 2017. Long noncoding RNA: Genome organization and mechanism of action. Adv. Exp. Med. Biol. 1008: 47-74. https://doi.org/10.1007/978-981-10-5203-3_2
- Almeida RS, Costa ESM, Coutinho LL, Garcia Gomes R, Pedrosa F, Massaro JD, et al. 2019. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia. Hematol. Oncol. 37: 103-112.
- Anastasiadou E, Jacob LS, Slack FJ. 2017. Non-coding RNA networks in cancer. Nat. Rev. Cancer 18: 5-18. https://doi.org/10.1038/nrc.2017.99
- Arman K, Saadat K, Igci YZ, Bozgeyik E, Ikeda MA, Cakmak EA, et al. 2020. Long noncoding RNA ERICD interacts with ARID3A via E2F1 and regulates migration and proliferation of osteosarcoma cells. Cell Biol. Int. 44: 2263-2274. https://doi.org/10.1002/cbin.11434
- Botti G, Giordano A, Feroce F, De Chiara AR, Cantile M. 2019. Noncoding RNAs as circulating biomarkers in osteosarcoma patients. J. Cell. Physiol. 234: 19249-19255. https://doi.org/10.1002/jcp.28744
- Correia de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M. 2019. Deciphering miRNAs' action through miRNA editing. Int. J. Mol. Sci. 20: 6249. https://doi.org/10.3390/ijms20246249
- Czarnecka AM, Synoradzki K, Firlej W, Bartnik E, Sobczuk P, Fiedorowicz M, et al. 2020. Molecular biology of osteosarcoma. Cancers (Basel) 12: 2130. https://doi.org/10.3390/cancers12082130
- de Azevedo JWV, de Medeiros Fernandes TAA, Fernandes JV, Jr., de Azevedo JCV, Lanza DCF, Bezerra CM, et al. 2020. Biology and pathogenesis of human osteosarcoma. Oncol. Lett. 19: 1099-1116.
- Gao C, Gao J, Zeng G, Yan H, Zheng J, Guo W. 2021. MicroRNA-629-5p promotes osteosarcoma proliferation and migration by targeting caveolin 1. Braz. J. Med. Biol. Res. 54: e10474. https://doi.org/10.1590/1414-431x202010474
- Gao L, Xiong DD, He RQ, Yang X, Lai ZF, Liu LM, et al. 2019. MIR22HG as a tumor suppressive lncRNA In HCC: a comprehensive analysis integrating RT-qPCR, mRNA-Seq, and microarrays. Onco Targets Ther. 12: 9827-9848. https://doi.org/10.2147/OTT.S227541
- Han M, Wang S, Fritah S, Wang X, Zhou W, Yang N, et al. 2020. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling. Brain 143: 512-530. https://doi.org/10.1093/brain/awz406
- Hu X, Sood AK, Dang CV, Zhang L. 2018. The role of long noncoding RNAs in cancer: the dark matter matters. Curr. Opin. Genet. Dev. 48: 8-15. https://doi.org/10.1016/j.gde.2017.10.004
- Izadpanah S, Shabani P, Aghebati-Maleki A, Baghbani E, Baghbanzadeh A, Fotouhi A, et al. 2019. Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy. Biomed. Pharmacother. 111: 873-881. https://doi.org/10.1016/j.biopha.2018.12.106
- Jin C, Jia L, Tang Z, Zheng Y. 2020. Long non-coding RNA MIR22HG promotes osteogenic differentiation of bone marrow mesenchymal stem cells via PTEN/ AKT pathway. Cell Death Dis. 11: 601. https://doi.org/10.1038/s41419-020-02813-2
- Jin H, Luo S, Wang Y, Liu C, Piao Z, Xu M, et al. 2017. miR-135b stimulates osteosarcoma recurrence and lung metastasis via notch and Wnt/β-Catenin signaling. Mol. Ther. Nucleic Acids 8: 111-122. https://doi.org/10.1016/j.omtn.2017.06.008
- Kager L, Tamamyan G, Bielack S. 2017. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncol. 13: 357-368. https://doi.org/10.2217/fon-2016-0261
- Kotake Y, Goto T, Naemura M, Inoue Y, Okamoto H, Tahara K. 2017. Long noncoding RNA PANDA positively regulates proliferation of osteosarcoma cells. Anticancer Res. 37: 81-85. https://doi.org/10.21873/anticanres.11292
- Li X, Li N, Niu Q, Zhu H, Wang Z, Hou Q. 2020. Elevated expression of miR-629 predicts a poor prognosis and promotes cell proliferation, migration, and invasion of osteosarcoma. Onco. Targets Ther. 13: 1851-1857. https://doi.org/10.2147/OTT.S232479
- Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408. https://doi.org/10.1006/meth.2001.1262
- Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. 2006. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat. Rev. 32: 423-436. https://doi.org/10.1016/j.ctrv.2006.05.005
- Meazza C, Scanagatta P. 2016. Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev. Anticancer Ther. 16: 543-556. https://doi.org/10.1586/14737140.2016.1168697
- Melamed P, Yosefzon Y, David C, Tsukerman A, Pnueli L. 2018. Tet enzymes, variants, and differential effects on function. Front. Cell Dev. Biol. 6: 22. https://doi.org/10.3389/fcell.2018.00022
- Misawa A, Orimo H. 2018. lncRNA HOTAIR inhibits mineralization in osteoblastic osteosarcoma cells by epigenetically repressing ALPL. Calcif. Tissue Int. 103: 422-430. https://doi.org/10.1007/s00223-018-0434-0
- Otoukesh B, Abbasi M, Gorgani HO, Farahini H, Moghtadaei M, Boddouhi B, et al. 2020. MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma. Cancer Cell Int. 20: 254. https://doi.org/10.1186/s12935-020-01342-4
- Rao-Bindal K, Kleinerman ES. 2011. Epigenetic regulation of apoptosis and cell cycle in osteosarcoma. Sarcoma 2011: 679457. https://doi.org/10.1155/2011/679457
- Ross SE, Bogdanovic O. 2019. TET enzymes, DNA demethylation and pluripotency. Biochem. Soc. Trans. 47: 875-885. https://doi.org/10.1042/BST20180606
- Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. 2018. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 109: 2093-2100. https://doi.org/10.1111/cas.13642
- Sekar D, Mani P, Biruntha M, Sivagurunathan P, Karthigeyan M. 2019. Dissecting the functional role of microRNA 21 in osteosarcoma. Cancer Gene Ther. 26: 179-182. https://doi.org/10.1038/s41417-019-0092-z
- Shabani P, Izadpanah S, Aghebati-Maleki A, Baghbani E, Baghbanzadeh A, Fotouhi A, et al. 2019. Role of miR-142 in the pathogenesis of osteosarcoma and its potential as therapeutic approach. J. Cell. Biochem. 120: 4783-4793. https://doi.org/10.1002/jcb.27857
- Song Y-N, Shi L-L, Liu Z-Q, Qiu G-F. 2014. Global analysis of the ovarian microRNA transcriptome: implication for miR-2 and miR133 regulation of oocyte meiosis in the Chinese mitten crab, Eriocheirsinensis (Crustacea:Decapoda). BMC Genomics 15: 547. https://doi.org/10.1186/1471-2164-15-547
- Su W, Feng S, Chen X, Yang X, Mao R, Guo C, et al. 2018. Silencing of long noncoding RNA MIR-22HG triggers cell survival/death signaling via oncogenes YBX1, MET, and p21 in lung cancer. Cancer Res. 78: 3207-3219. https://doi.org/10.1158/0008-5472.CAN-18-0222
- Tang Q, Jiang X, Ma S, Wang L, Li R, Ma J. 2020. MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation. Biosci. Rep. 40: SR20193991.
- Trilla-Fuertes L, Miranda N, Castellano D, Lopez-Vacas R, Farfan Tello CA, de Velasco G, et al. 2020. miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma. PLoS One 15: e0229075. https://doi.org/10.1371/journal.pone.0229075
- Uhr K, Prager-van der Smissen WJC, Heine AAJ, Ozturk B, van Jaarsveld MTM, Boersma AWM, et al. 2019. MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines. PLoS One 14: e0216400. https://doi.org/10.1371/journal.pone.0216400
- Wang JY, Yang Y, Ma Y, Wang F, Xue A, Zhu J, et al. 2020. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed. Pharmacother. 121: 109627. https://doi.org/10.1016/j.biopha.2019.109627
- Wen JJ, Ma YD, Yang GS, Wang GM. 2017. Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma. Eur. Rev. Med. Pharmacol. Sci. 21: 498-503.
- Xiao X, Wang W, Wang Z. 2014. The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma. Paediatr. Drugs 16: 503-512. https://doi.org/10.1007/s40272-014-0095-z
- Xu S, Gong Y, Yin Y, Xing H, Zhang N. 2020. The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis. Biomed. Pharmacother. 127: 110141. https://doi.org/10.1016/j.biopha.2020.110141
- Ye Z, Li J, Han X, Hou H, Chen H, Zheng X, et al. 2016. TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells. J. Exp. Clin. Cancer Res. 435: 72.
- Zhang J, Yan YG, Wang C, Zhang SJ, Yu XH, Wang WJ. 2015. MicroRNAs in osteosarcoma. Clin. Chim. Acta 444: 9-17. https://doi.org/10.1016/j.cca.2015.01.025
- Zhang L, Li C, Su X. 2020. Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers. J. Exp. Clin. Cancer Res. 39: 271. https://doi.org/10.1186/s13046-020-01784-8
- Zheng Y, Wang G, Chen R, Hua Y, Cai Z. 2018. Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications. Stem Cell Res. Ther. 9: 22. https://doi.org/10.1186/s13287-018-0780-x
- Zhou RS, Zhang EX, Sun QF, Ye ZJ, Liu JW, Zhou DH, et al. 2019. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer 19: 779. https://doi.org/10.1186/s12885-019-5983-8